Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Exacerbation Endpoints

Gelijkaardige items

• Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease (COPD): A Meta-Analysis of METREX and METREO Patient-Reported Outcomes, Response to Therapy and Lung Function
  door: Chapman, K, et al.
  Gepubliceerd in: (2018)
• Mepolizumab for eosinophilic COPD
  door: Sciurba, F, et al.
  Gepubliceerd in: (2018)
• Late breaking abstract - Dose-ranging study of mepolizumab in eosinophilic COPD
  door: Pavord, I, et al.
  Gepubliceerd in: (2017)
• Mepolizumab for eosinophilic chronic obstructive pulmonary disease
  door: Pavord, I, et al.
  Gepubliceerd in: (2017)
• Clinical characterisation of exacerbations of severe eosinophilic asthma occurring on mepolizumab and placebo
  door: Howell, I, et al.
  Gepubliceerd in: (2024)